Cas no 56283-74-0 (Monensin,16-deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)-)

Monensin,16-deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)- structure
56283-74-0 structure
Product Name:Monensin,16-deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)-
CAS No:56283-74-0
MF:C37H62O12
MW:698.880993366241
CID:372118
PubChem ID:71454116
Update Time:2025-04-19

Monensin,16-deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)- Chemical and Physical Properties

Names and Identifiers

    • Monensin,16-deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)-
    • LAIDLOMYCIN, POTASSIUM SALT
    • 16-Deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)monensin
    • 4-(9-hydroxy-2-{5'-[6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl]-2,3'-dimethyloctahydro-2,2'-bifuran-5-yl}-2,8-dimet
    • BRN 1675244
    • Laidlomicina
    • Laidlomicina [INN-Spanish]
    • Laidlomycin [INN:BAN]
    • Laidlomycine
    • Laidlomycine [INN-French]
    • Laidlomycinum
    • Laidlomycinum [INN-Latin]
    • UNII-MI3S6ZF5QE
    • LAIDLOMYCIN [MI]
    • Laidlomicina (INN-Spanish)
    • Laidlomycin
    • MI3S6ZF5QE
    • DTXSID401024015
    • ZNBNBTIDJSKEAM-NISBWGIBSA-N
    • CSU-1
    • 56283-74-0
    • LAIDLOMYCIN [INN]
    • EINECS 260-095-1
    • Laidlomycinum (INN-Latin)
    • (2S,3R,4R)-4-[(2S,5R,7S,8R,9S)-7-hydroxy-2-[(2R,5S)-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-2-methyl-3-propanoyloxypentanoic acid
    • Monensin, 16-deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)-
    • 16-Deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl) monensin
    • CHEMBL2205250
    • Q15725701
    • Laidlomycine (INN-French)
    • AKOS040746980
    • Inchi: 1S/C37H62O12/c1-10-28(40)45-30(24(7)33(41)42)23(6)31-22(5)25(39)17-36(47-31)14-13-34(8,49-36)27-11-12-35(9,46-27)32-20(3)16-26(44-32)29-19(2)15-21(4)37(43,18-38)48-29/h19-27,29-32,38-39,43H,10-18H2,1-9H3,(H,41,42)/t19-,20-,21+,22+,23-,24-,25-,26+,27+,29-,30+,31-,32+,34-,35-,36+,37-/m0/s1
    • InChI Key: ZNBNBTIDJSKEAM-NISBWGIBSA-N
    • SMILES: O1[C@H](CC[C@@]1(C)[C@H]1[C@@H](C)C[C@H]([C@@H]2[C@@H](C)C[C@@H](C)[C@@](CO)(O)O2)O1)[C@]1(C)CC[C@]2(C[C@@H]([C@@H](C)[C@@H]([C@@H](C)[C@H]([C@@H](C(=O)O)C)OC(CC)=O)O2)O)O1

Computed Properties

  • Exact Mass: 698.42412741g/mol
  • Monoisotopic Mass: 698.42412741g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 4
  • Hydrogen Bond Acceptor Count: 12
  • Heavy Atom Count: 49
  • Rotatable Bond Count: 11
  • Complexity: 1200
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 17
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 4.1
  • Topological Polar Surface Area: 170?2

Experimental Properties

  • Density: 1.0932 (rough estimate)
  • Melting Point: 151-153°
  • Boiling Point: 622.45°C (rough estimate)
  • Refractive Index: 1.6390 (estimate)
  • Specific Rotation: D22 +51.3° (c=0.2 in CHCl3)

Monensin,16-deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)- Security Information

  • Toxicity:LD50 in mice (mg/kg): 5 i.p.; 1 i.v.; 2.5 s.c. (Kitame)
Recommended suppliers
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shaanxi pure crystal photoelectric technology co. LTD
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Nanjing jingzhu bio-technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing jingzhu bio-technology Co., Ltd.